Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01367730 · ClinicalTrials.gov registry record
Assessment of Bone Micro-Architecture Using HR-pQCT
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 80
- Enrollment target
NCT01367730 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 80 participants.
The verdict
NCT01367730 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
In the context of male osteoporosis, we hypothesize that regional changes in trabecular bone, as well as changes in cortical porosity will play a major role, and thus also affect bone strength. In developing therapeutics the response of individual compartments, regional variations post-therapy will have considerable impact on selecting the therapies as well as monitoring response to therapy. This study, a precursor to other therapeutic trials, will lay the ground-work for the future.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2012-04 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01367730
The ClinicalTrials.gov registry entry for NCT01367730 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01367730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01367730 about?
NCT01367730 is a clinical study titled "Assessment of Bone Micro-Architecture Using HR-pQCT". In the context of male osteoporosis, we hypothesize that regional changes in trabecular bone, as well as changes in cortical porosity will play a major role, and thus also affect bone strength. In developing therapeutics the response of individual compartments, regional variations post-therapy will ...
What is the current status of trial NCT01367730?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2012-04. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01367730?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.